Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

April 22, 2027

Study Completion Date

April 22, 2027

Conditions

Oligometastatic Prostate CarcinomaProstate Adenocarcinoma

Interventions

DRUG

Abiraterone Acetate

Given abiraterone acetate

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

PROCEDURE

Computed Tomography

Undergo CT

BIOLOGICAL

Gonadotropin-releasing Hormone Analog

Given SC or IM

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Positron Emission Tomography

Undergo PET

OTHER

Questionnaire Administration

Ancillary studies

RADIATION

Radiation Therapy

Undergo radiation therapy

Trial Locations (1)

RECRUITING

Mayo Clinic in Arizona, Scottsdale